Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma
出版年份 2012 全文链接
标题
Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma
作者
关键词
-
出版物
VIRCHOWS ARCHIV
Volume 461, Issue 6, Pages 629-638
出版商
Springer Nature
发表日期
2012-10-12
DOI
10.1007/s00428-012-1324-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
- (2012) N. Rekhtman et al. CLINICAL CANCER RESEARCH
- International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
- (2011) William D. Travis et al. Journal of Thoracic Oncology
- ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach
- (2011) Giuseppe Pelosi et al. Journal of Thoracic Oncology
- p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
- (2011) Justin A Bishop et al. MODERN PATHOLOGY
- Optimal Immunohistochemical Markers For Distinguishing Lung Adenocarcinomas From Squamous Cell Carcinomas in Small Tumor Samples
- (2010) Jefferson Terry et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Overall survival with cisplatin-gemcitabine and bevacizumab or placebo as first-line therapy for nonsquamous non-small-cell lung cancer: results from a randomised phase III trial (AVAiL)
- (2010) M. Reck et al. ANNALS OF ONCOLOGY
- Discordance of Molecular Biomarkers Associated with Epidermal Growth Factor Receptor Pathway between Primary Tumors and Lymph Node Metastasis in Non-small Cell Lung Cancer
- (2010) Sarah Park et al. Journal of Thoracic Oncology
- Association of Epidermal Growth Factor Receptor Activating Mutations with Low ERCC1 Gene Expression in Non-small Cell Lung Cancer
- (2010) David R. Gandara et al. Journal of Thoracic Oncology
- Subtyping of Undifferentiated Non-small Cell Carcinomas in Bronchial Biopsy Specimens
- (2010) Peh Sun Loo et al. Journal of Thoracic Oncology
- Refining the Diagnosis and EGFR Status of Non-small Cell Lung Carcinoma in Biopsy and Cytologic Material, Using a Panel of Mucin Staining, TTF-1, Cytokeratin 5/6, and P63, and EGFR Mutation Analysis
- (2010) Andrew G. Nicholson et al. Journal of Thoracic Oncology
- Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer
- (2010) Giorgio Scagliotti et al. Journal of Thoracic Oncology
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- (2010) Eunice L. Kwak et al. NEW ENGLAND JOURNAL OF MEDICINE
- EGFRand K-rasMutations Along the Spectrum of Pulmonary Epithelial Tumors of the Lung and Elaboration of a Combined Clinicopathologic and Molecular Scoring System to Predict Clinical Responsiveness to EGFR Inhibitors
- (2009) Giuliana Sartori et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Review Article: A Reevaluation of the Clinical Significance of Histological Subtyping of Non—Small-Cell Lung Carcinoma: Diagnostic Algorithms in the Era of Personalized Treatments
- (2009) Giulio Rossi et al. INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
- Morphology and a Limited Number of Immunohistochemical Markers May Efficiently Subtype Non–Small-Cell Lung Cancer
- (2009) Giulio Rossi et al. JOURNAL OF CLINICAL ONCOLOGY
- Epidermal Growth Factor Receptor Mutations and the Clinical Outcome in Male Smokers with Squamous Cell Carcinoma of Lung
- (2009) Se Hoon Park et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Large Cell Carcinoma of the Lung
- (2009) Javier Pardo et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patients
- (2008) M I Galleges Ruiz et al. BRITISH JOURNAL OF CANCER
- Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Giorgio Vittorio Scagliotti et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation